Diana Conte Camerino Selected Research

Diana Conte Camerino Research Topics

5	Myotonia 01/2017 - 02/2012
4	Muscular Diseases (Myopathy) 01/2017 - 01/2004
3	Myotonia Congenita (Thomsen Disease) 09/2015 - 10/2013
2	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 02/2005
2	Muscular Atrophy (Muscle Atrophy) 01/2016 - 01/2015
2	Atrophy 01/2015 - 11/2007
2	Paralysis (Palsy) 01/2012 - 01/2006
1	Potassium aggravated myotonia 05/2016
1	Myotoxicity 01/2016
1	Hypertension (High Blood Pressure) 10/2014
1	Hypokalemia 01/2013
1	Hyperkalemia 01/2013
1	Neuralgia (Stump Neuralgia) 02/2012
1	Channelopathies 01/2006
1	Fibrosis (Cirrhosis) 02/2005
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2003
1	Muscle Weakness 10/2002
1	Inflammation (Inflammations) 10/2002

4	Pharmaceutical PreparationsIBA 01/2017 - 10/2002
4	Mexiletine (Mexitil)FDA LinkGeneric 01/2017 - 02/2012
3	Sodium Channel BlockersIBA 01/2017 - 02/2013
3	ChloridesIBA 09/2015 - 10/2002
3	CalciumIBA 10/2014 - 10/2002
2	AntioxidantsIBA 01/2017 - 01/2015
2	Polymethyl Methacrylate (Sol)IBA 01/2015 - 11/2007
2	Amino Acids FDA Link 01/2015 - 01/2004
2	Chloride Channels (Chloride Channel)IBA 05/2014 - 10/2013
2	Taurine FDA Link 01/2004 - 10/2002
2	SteroidsIBA 01/2003 - 10/2002
1	pyrrolineIBA 01/2017
1	Sodium Channels (Sodium Channel)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	CLC-1 channelIBA 09/2015
1	Anabolic Androgenic SteroidsIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Nandrolone (Nortestosterone)IBA 01/2015
1	Stromal Interaction Molecule 1IBA 10/2014
1	Antihypertensive Agents (Antihypertensives)IBA 10/2014
1	AcidsIBA 05/2014
1	Tocainide (Tonocard)FDA Link 03/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2013
1	iberiotoxinIBA 01/2013
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2013
1	ProdrugsIBA 02/2012
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2006
1	Insulin (Novolin)FDA Link 01/2006
1	Carbonic Anhydrase InhibitorsIBA 01/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2005
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2005
1	Ion Channels (Ion Channel)IBA 01/2004
1	Insulin-Like PeptidesIBA 10/2002